期刊
MOLECULAR THERAPY
卷 11, 期 6, 页码 823-842出版社
CELL PRESS
DOI: 10.1016/j.ymthe.2005.01.020
关键词
AIDS; cellular cofactors; gene therapy; transduction; viral vectors
资金
- NCRR NIH HHS [RR00043] Funding Source: Medline
- NHLBI NIH HHS [HL074704] Funding Source: Medline
- NIAID NIH HHS [AI49057, AI48244, AI061839, AI29329, AI41399, AI42552, AI50492, AI054188, AI54907] Funding Source: Medline
- NIMH NIH HHS [MH70287] Funding Source: Medline
Progress in developing effective gene transfer approaches to treat HIV-1 infection has been steady. Many different transgenes have been reported to inhibit HIV-1 in vitro. However, effective translation of such results to clinical practice, or even to animal models of AIDS, has been challenging. Among the reasons for this failure are uncertainty as to the most effective cell population(s) to target, the diffuseness of these target cells in the body, and ineffective or insufficiently durable gene delivery. Better understanding of the HIV-1 replicative cycle, host factors involved in HIV-1 infection, vector biology and application, transgene technology, animal models, and clinical study design have all contributed vastly to planning current and future strategies for application of gene therapeutic approaches to the treatment of AIDS. This review focuses on the newest developments in these areas and provides a strong basis for renewed optimism that gene therapy will have an important role to play in treating people infected with HIV-1.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据